Jonathan Goldstein

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations

Pharmacy, Neurology, Pharmacotherapy +15

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability

K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1998 · 512 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Regional variation of Guillain-Barré syndrome

Alex Y. Doets, Christine Verboon, Bianca van den Berg et al. · Brain · 2018 · 330 citations · Full text

Medicine, Internal Medicine, Neurology +16

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy

J. Robinson Singleton, Billie Bixby, James W. Russell et al. · Journal of the Peripheral Nervous System · 2008 · 230 citations · Full text

Medicine, Neurology, Neuroscience +16

Clinical findings in MuSK‐antibody positive myasthenia gravis: A U.S. experience

Mamatha Pasnoor, Gil I. Wolfe, Sharon Nations et al. · Muscle & Nerve · 2009 · 191 citations

Life Sciences, Endocrinology, Immunology +12